News

For more than a decade, this is usually the time period when companies tout the steps they’re taking to lower carbon ...
Vepdegestrant showed a benefit for patients with ER-positive, HER2-negative, ESR1-mutated breast cancer who had previously received endocrine-based therapy.
Wolfspeed bankruptcy watch, North Carolina lands more data centers, Duke University's funding crunch, and an AI companion ...
Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...
A Connecticut doctor who is an expert in his field said it is “one of the silent diseases that does not get the respect it ...
Kindler and his wife, Sharon Sullivan, who works in the performing arts, have listed a four-bedroom, four-bath condo on West ...
Brad Lerman "and I have been talking about what makes sense for him and for our legal team and Brad will be leaving Starbucks ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Bayer has taken another step toward achieving its €3 billion peak sales estimate for androgen receptor inhibitor Nubeqa, ...
Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than ...